A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution

Phase 3 Completed 120 enrolled American Genomics, LLC

RandomizedParallel-groupDouble-blindSupportive care

Summary

This is a Phase 3, randomized, placebo-controlled, double masked, parallel design study in healthy subjects performed in the US. It is designed to evaluate the safety and anesthetic efficacy of AG-920 Sterile Topical Ophthalmic Solution.

Timeline

Start: 2021-03-30
Primary completion: 2021-05-06
Completion: 2021-05-10

Publications

Gonzalez VH, Wirta DL, Uram M, Schupp A, Widmann M, Novack GD. Two Randomized, Double-masked, Placebo-controlled Studies of the Local Anesthetic Effect of Articaine Ophthalmic Solution. Clin Ophthalmol. 2023 May 10;17:1357-1365. doi: 10.2147/OPTH.S409241. eCollection 2023.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Articaine	Other / unclassified	—	Topical

Indications

No indication recorded.